← Open Payments lookup

JENNIFER BEAULIEU: Open Payments

NPI 1477258341 · PAYETTE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$965 in 23 payments from 7 companies in 2025. Trend: 2023 $21 · 2024 $585 · 2025 $965

Food & beverage: $874Education: $91
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.3$237
Otsuka America Pharmaceutical, Inc.2$210
ABBVIE INC.13$174
E.R. Squibb & Sons, L.L.C.1$127
Teva Pharmaceuticals USA, Inc.2$115
Alkermes, Inc.1$87
AstraZeneca Pharmaceuticals LP1$14

Products named: VRAYLAR, INGREZZA, COBENFY, REXULTI, ABILIFY MAINTENA, LYBALVI, AUSTEDO XR, BREZTRI.

Industry payments across ID — which companies pay providers there.